Detalhe da pesquisa
1.
CAR/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection.
PLoS Pathog
; 18(2): e1009831, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35130312
2.
Assessment of anti-CD20 antibody pre-treatment for augmentation of CAR-T cell therapy in SIV-infected rhesus macaques.
Front Immunol
; 14: 1101446, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36825014
3.
Development of an anti-CAR antibody response in SIV-infected rhesus macaques treated with CD4-MBL CAR/CXCR5 T cells.
Front Immunol
; 13: 1032537, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36582226